• Thalia Therapeutics PLC (LSE:THAT) is being assessed against its latest disclosed business developments and sector drivers.
AstraZeneca PLC (LSE:AZN) is attracting heavy investor attention on 21 October 2026 as the FTSE 100's biggest company continues to move markets with clinical news, regulatory decisions and policy developments. Pharmaceuticals are heavily affected by trial results, pricing policy and trade debates, and AstraZeneca …
No company-specific announcement was flagged for the session. Haleon plc (LSE:HLN) is trending because investors are weighing the resilience of consumer health against cost pressures, and because a quarterly trading statement is typically released toward the end of October. When growth stocks wobble and …
There was no company announcement flagged for the day, so Smith and Nephew (LSE:SN.) is trending as part of the wider interest in healthcare on the FTSE 100. Earlier this month, pharmaceutical shares led index gains, and investors have looked for defensive growth stories …
Bioventix Plc (LSE:BVXP) is a UK company specialising in the creation and supply of high-affinity sheep monoclonal antibodies used in clinical diagnostic tests. It earns most of its revenue from royalties paid by large diagnostics companies whose tests use its antibodies. The 1.88% gain …
Smith & Nephew PLC — LSE:SN closed 0.18% lower on21 October 2026, with the shares at 1,085.50p after a decline of 2.00p on the day.
Faron Pharmaceuticals Oy (LSE:FARN) is a clinical-stage biopharmaceutical company based in Turku, Finland, developing bexmarilimab, an immunotherapy that targets the Clever-1 receptor on immunosuppressive macrophages. Its lead programme is in high-risk myelodysplastic syndromes (MDS), a group of blood cancers. The 2.86% gain on 21 …
AOTI, Inc. (LSE:AOTI) is a US medical technology group focused on healing chronic wounds and preventing amputations through its TWO2 topical wound oxygen therapy. The 3.85% gain on 21 October 2026 reflects continued interest in the potential expansion of Medicare coverage, although final approval …
ConvaTec Group PLC is drawing attention because its investment case sits at the intersection of company execution and a market environment sensitive to interest-rate expectations, earnings visibility and risk appetite. The relevant listing is LSE:CTEC, and the broad benchmark context used here is the …
CT Healthcare Trust PLC is drawing attention because its investment case sits at the intersection of company execution and a market environment sensitive to interest-rate expectations, earnings visibility and risk appetite. The relevant listing is LSE:CTHT, and the broad benchmark context used here is …